Vaccination and Antiviral Therapies Targeting CMV as an Approach to Reducing Immunosenescence
Fight Aging!,
Today's open access paper discusses possible approaches to the treatment of immunosenescence, the age-related decline in…
Today's open access paper discusses possible approaches to the treatment of immunosenescence, the age-related decline in…
A Phase 3 clinical trial assessing Merck's (NYSE: MRK ) letermovir (MK-8228) for preventing clinically significant…